Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Commerce international · 19/05/20261 min de lecture
Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Amending the Complaint and Notice of Investigation
Traduction automatique locale · Langue originale de la source
Résumé
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 45) of the presiding Chief administrative law judge ("Chief ALJ") granting complainant's unopposed motion to amend the complaint and notice of investigation to reflect respondent Ascendis Pharma, Inc.'s corporate name change to Ascendis Pharma, LLC.
Langue originale de la source: Federal Register — International Trade CommissionOuvrir le communiqué original →